IBDEI114 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16731,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,16731,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,16731,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,16732,0)
 ;;=Z82.69^^61^776^37
 ;;^UTILITY(U,$J,358.3,16732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16732,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,16732,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,16732,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,16733,0)
 ;;=Z83.3^^61^776^20
 ;;^UTILITY(U,$J,358.3,16733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16733,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,16733,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,16733,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,16734,0)
 ;;=Z83.2^^61^776^16
 ;;^UTILITY(U,$J,358.3,16734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16734,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,16734,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,16734,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,16735,0)
 ;;=Z82.71^^61^776^40
 ;;^UTILITY(U,$J,358.3,16735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16735,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,16735,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,16735,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,16736,0)
 ;;=Z82.1^^61^776^15
 ;;^UTILITY(U,$J,358.3,16736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16736,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,16736,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,16736,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,16737,0)
 ;;=Z82.2^^61^776^19
 ;;^UTILITY(U,$J,358.3,16737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16737,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
 ;;^UTILITY(U,$J,358.3,16737,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,16737,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,16738,0)
 ;;=Z84.0^^61^776^41
 ;;^UTILITY(U,$J,358.3,16738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16738,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,16738,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,16738,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,16739,0)
 ;;=Z82.79^^61^776^18
 ;;^UTILITY(U,$J,358.3,16739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16739,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
 ;;^UTILITY(U,$J,358.3,16739,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,16739,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,16740,0)
 ;;=Z84.89^^61^776^39
 ;;^UTILITY(U,$J,358.3,16740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16740,1,3,0)
 ;;=3^Family Hx of Other Spec Conditions
 ;;^UTILITY(U,$J,358.3,16740,1,4,0)
 ;;=4^Z84.89
 ;;^UTILITY(U,$J,358.3,16740,2)
 ;;=^5063393
 ;;^UTILITY(U,$J,358.3,16741,0)
 ;;=Z81.1^^61^776^12
 ;;^UTILITY(U,$J,358.3,16741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16741,1,3,0)
 ;;=3^Family Hx of Alcohol Abuse/Dependence
 ;;^UTILITY(U,$J,358.3,16741,1,4,0)
 ;;=4^Z81.1
 ;;^UTILITY(U,$J,358.3,16741,2)
 ;;=^5063359
 ;;^UTILITY(U,$J,358.3,16742,0)
 ;;=Z82.62^^61^776^38
 ;;^UTILITY(U,$J,358.3,16742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16742,1,3,0)
 ;;=3^Family Hx of Osteoporosis
 ;;^UTILITY(U,$J,358.3,16742,1,4,0)
 ;;=4^Z82.62
 ;;^UTILITY(U,$J,358.3,16742,2)
 ;;=^5063372
 ;;^UTILITY(U,$J,358.3,16743,0)
 ;;=Z83.71^^61^776^17
 ;;^UTILITY(U,$J,358.3,16743,1,0)
 ;;=^358.31IA^4^2
